Illumina, Inc. offers the Genome Analyzer IIe sequencing system, designed to provide a lower-priced entry point into next-generation sequencing. Priced at $250,000, the new system leverages the architecture of Illumina’s Genome Analyzer IIx and its sequencing-by-synthesis chemistry to generate approximately 200 million paired-end reads and 20 gigabases (Gb) of data per run at launch.
As Illumina introduces advances to increase the output of the Genome Analyzer IIx to 95 Gb, the output of the Genome Analyzer IIe is expected to reach 40 Gb and 300 million paired-end reads per run.
The system’s price point, coupled with its ease of use and proven sequencing technology, positions it for smaller laboratories interested in next-generation sequencing.
This product was featured in Drug Discovery & Development magazine: Vol. 13, No. 3, April 2010, p. 17.